OneMedPlace Announces “OneMedForum 2011” Finance Conference for Emerging Healthcare and Life Science Companies

OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.

Read more »

Companies Presenting at Advamed2010

More than 50 innovative medical technology companies from around the world will present their company profiles to potential investors, partners and industry stakeholders at AdvaMed 2010: The MedTech Conference, being held October 18-20, 2010 in Washington, D.C.

Read more »

Genomics Researchers Have a Bone to Pick with Multiple Myeloma

Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.

Read more »

Giving Peyronie’s Patients More Treatment Options

An disorder frequently associated with ED is Peyronie’s disease.

Read more »

The 1st Annual Miami Medical Investors Conference: November 12, 2010

LifeTech Capital invites you to their 1st Annual Miami Medical Investors Conference November 12th at the brand new JW Marriott Marquis Miami.

Read more »

Urovalve Bladder Management System Shows Early Promise in Clinical Trial

Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.

Read more »

IN3 Summit Will Offer Partnering Opportunities for Medtech Innovators with Top Investors & Corporate Acquirers in San Francisco on October 27-29, 2010

The medtech industry’s leading conference for face-to-face dialogue with top investors, large device companies, and the hottest emerging innovators.

Read more »

China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential

China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.

Read more »

Advanced Life Sciences: Addressing Antibiotic Resistance in Infectious Disease Market

The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.

Read more »

Protected: Amarantus BioSciences Management Video

There is no excerpt because this is a protected post.

Read more »